Capecitabine for ER-positive versus ER-negative breast cancer

Alison M. White, Peter K.H. Lau, Andrew D. Redfern, Max K. Bulsara

Research output: Contribution to journalArticlepeer-review

1 Citation (Scopus)

Abstract

This is the protocol for a review and there is no abstract. The objectives are as follows: To assess the effects of chemotherapy regimens containing capecitabine compared with regimens not containing capecitabine for women with ER-positive versus ER-negative breast cancer.

Original languageEnglish
Article numberCD011220
JournalCochrane Database of Systematic Reviews
Volume2014
Issue number8
DOIs
Publication statusPublished - 3 Aug 2014
Externally publishedYes

Fingerprint

Dive into the research topics of 'Capecitabine for ER-positive versus ER-negative breast cancer'. Together they form a unique fingerprint.

Cite this